sulfinpyrazone has been researched along with Anoxemia in 5 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Excerpt | Relevance | Reference |
---|---|---|
"Our results suggest that hypoxemia is associated with shortened platelet survival time and that platelets may, therefore, be involved in the thromboembolic complications that develop in patients with hypoxemia." | 1.26 | Platelet survival time in patients with hypoxemia and pulmonary hypertension. ( Ellis, JH; Genton, E; Steele, P; Weily, HS, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keller, R | 1 |
Mlczoch, J | 1 |
Tucker, A | 1 |
Weir, EK | 1 |
Reeves, JT | 1 |
Grover, RF | 1 |
Steele, P | 2 |
Ellis, JH | 2 |
Weily, HS | 1 |
Genton, E | 2 |
Keith, IM | 1 |
Will, JA | 1 |
Huxtable, RJ | 1 |
Weir, K | 1 |
1 review available for sulfinpyrazone and Anoxemia
Article | Year |
---|---|
[Adult respiratory distress syndrome (ARDS) (author's transl)].
Topics: Adrenal Cortex Hormones; Alkalosis; Barotrauma; Humans; Hypoxia; Myocardial Infarction; Positive-Pre | 1981 |
4 other studies available for sulfinpyrazone and Anoxemia
Article | Year |
---|---|
Platelet-mediated pulmonary hypertension and hypoxia during pulmonary microembolism: reduction by platelet inhibition.
Topics: Animals; Blood Platelets; Dogs; Female; Heparin; Hypertension, Pulmonary; Hypoxia; Male; Pulmonary E | 1978 |
Platelet survival time in patients with hypoxemia and pulmonary hypertension.
Topics: Blood Platelets; Cell Survival; Female; Humans; Hypertension, Pulmonary; Hypoxia; Male; Oxygen; Sulf | 1977 |
Platelet survival time in severe chronic airway obstruction.
Topics: Airway Obstruction; Blood Cell Count; Blood Platelets; Cell Survival; Chronic Disease; Humans; Hypox | 1975 |
Anti-platelet agents reduce morphological changes of chronic hypoxic pulmonary hypertension.
Topics: Animals; Dipyridamole; Flunarizine; Heart; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Male; | 1987 |